menu_open Columnists
Sam Forsdick

Sam Forsdick

Fortune

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Weight-loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult

A clinical trial failure and U.S. competition have been tough for the Danish pharmaceutical firm. CFO Karsten Munk Knudsen says the company is...

06.08.2026 3

Fortune

Sam Forsdick

The IPO hype cycle returns

In 2016, Fortune cautioned investors of a tech IPO reckoning. A decade on, the warning is worth heeding once more as a new set of companies chase a...

28.07.2026 8

Fortune

Sam Forsdick

Marketing’s new mandate: Why AI is forcing CMOs to think like ‘mini CEOs’

Fortune hosted a panel of marketing leaders following the Cannes Lions International Festival of Creativity to discuss AI’s impact on the profession...

10.07.2026 10

Fortune

Sam Forsdick

The Iran conflict saw jet fuel prices soar—when you use 1.88 million tonnes a year, how you respond really matters (just ask DHL)

As jet fuel prices doubled, DHL Express has diversified supplies, rerouted aircraft and shifted to sustainable alternatives to keep its 295 planes...

01.07.2026 10

Fortune

Sam Forsdick

Roche and Nestlé fear talent crunch as Switzerland puts population cap to the polls

The proposed 10 million person limit could ruin Switzerland’s reputation as a business hub and risks harming one of Europe’s strongest economies,...

12.06.2026 20

Fortune

Sam forsdick